NanoMosaic

NanoMosaic is a life sciences company in Woburn, United States, founded in 2018. It has raised $40.8M across 1 round, most recently a $40.8M Series A in December 2021.

Nano-scale molecular profiling, screening and discovery

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$40.8M
Last Round
$40.8M Series ADec 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

NanoMosaic is a Boston-area biotechnology company developing a next-generation protein interrogation platform powered by proprietary nanoneedle technology licensed from Harvard University. The company's MosaicNeedles™ platform enables high-throughput, ultrasensitive detection and quantification of proteins, nucleic acids, and other analytes on a single chip, supporting early disease detection, prognostic monitoring, and biomarker discovery. NanoMosaic's tools are designed for researchers in oncology, neurology, and gene therapy, offering a workflow that integrates seamlessly with existing laboratory processes. The platform has been applied to developing clinical biomarker tests for conditions including cancer and neurological diseases.

Summary

It lists 11–50 employees. It has raised $40.8M in total across 1 round, most recently a $40.8M Series A round in Dec 2021.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2021
$40.8M

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NanoMosaic on Indexed.vc
<a href="https://indexed.vc/companies/nanomosaic"><img src="https://indexed.vc/api/badge/company/nanomosaic" alt="NanoMosaic on Indexed.vc" width="260" height="76" /></a>